Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Other Non-Current Assets: 2009-2021

Historic Other Non-Current Assets for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $33.8 million.

  • Avadel Pharmaceuticals' Other Non-Current Assets fell 69.24% to $11.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $11.7 million, marking a year-over-year decrease of 69.24%. This contributed to the annual value of $33.8 million for FY2021, which is 35.44% up from last year.
  • Avadel Pharmaceuticals' Other Non-Current Assets amounted to $33.8 million in FY2021, which was up 35.44% from $24.9 million recorded in FY2020.
  • In the past 5 years, Avadel Pharmaceuticals' Other Non-Current Assets ranged from a high of $39.3 million in FY2019 and a low of $10.2 million during FY2017.
  • For the 3-year period, Avadel Pharmaceuticals' Other Non-Current Assets averaged around $32.7 million, with its median value being $33.8 million (2021).
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first spiked by 252.68% in 2018, then slumped by 36.50% in 2020.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Other Non-Current Assets stood at $10.2 million in 2017, then skyrocketed by 252.68% to $36.1 million in 2018, then rose by 8.65% to $39.3 million in 2019, then plummeted by 36.50% to $24.9 million in 2020, then surged by 35.44% to $33.8 million in 2021.